Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
17,174,052
-
Shares change
-
+334,102
-
Total reported value, excl. options
-
$159,885,671
-
Value change
-
+$3,968,740
-
Put/Call ratio
-
61%
-
Number of buys
-
43
-
Number of sells
-
-17
-
Price
-
$9.31
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q2 2019
80 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q2 2019.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,174,052 shares
of 86,559,040 outstanding shares and own 20% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3,277,282 shares), MPM ASSET MANAGEMENT LLC (2,168,691 shares), BVF INC/IL (1,764,784 shares), BlackRock Inc. (1,681,507 shares), 683 Capital Management, LLC (1,615,955 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,475,000 shares), VANGUARD GROUP INC (1,029,150 shares), DIMENSIONAL FUND ADVISORS LP (944,450 shares), RENAISSANCE TECHNOLOGIES LLC (431,900 shares), and STATE STREET CORP (324,546 shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.